太航(02343.HK)續漲10%破頂交投活躍 首季小靈便型乾散貨日均收入倍增獲美銀升價
太平洋航運(02343.HK)公佈首季小靈便型乾散貨日均收入倍增,美銀證券隨即上調太航目標價。該股三連升,尤其是今天跑贏同業兼突破上週一及去年9月所造「雙頂」紀錄高位(4.55元),最高見4.7元,現報4.67元,續漲10%,成交急增至8,800萬股。
太航公佈,首季小靈便型及超靈便型乾散貨船按期租合約對等基準日均收入分別達23,810美元及32,510美元,按年增長117%及122%。美銀證券隨即上調太航目標價約4.5%至7元及重申「買入」評級,以反映公司上半年交易更新較預期好,將其未來三年盈測平均上調八千萬美元。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.